Belong.Life Launches App to Support Multiple Sclerosis Patients and Professionals
Product News May 05, 2020
Belong.Life, a developer of social networks for managing and navigating treatments, and the creator of the world’s largest social network for cancer patients, has announced the launch of its new free and anonymous AI-powered social networking and navigation platform for multiple sclerosis patients, caregivers and healthcare professionals – BelongMS. The app can be downloaded for Android and iOS.
The new app follows the success of Belong’s global social networking and navigation app for cancer management, the largest platform of its kind. BelongMS utilizes proprietary machine learning algorithms and domain expertise to provide hyper-personalized information to support patients throughout the MS journey, while uncovering new insights into patient journeys. This includes support groups and direct access to medical professionals, including neurologists, radiologists, urologists, and others who can answer patient questions. The app also provides useful tools including a medical binder manager to store and organize medical records in one place, with the option to share them securely and privately with family members or physicians. A clinical trial matching feature is also available, utilizing natural language processing algorithms to analyze all available trials around the globe to match patients within 2 weeks, on average.
“We are leveraging our market-proven experience in patient engagement, backed by disruptive technology, to provide effective support for patients across the healthcare continuum,” said Co-Founder and CEO of Belong.Life Eliran Malki. “People who receive challenging diagnoses need to make critical decisions and have access to the relevant data and support they need. Belong is providing a unique comprehensive support and management solution where patients can share and learn from their peers, connect with professionals and better navigate their unique journey all on one app.”
BelongMS was initially launched in Israel, with 1 in 4 local MS patients now engaging with the app. The app will now be available globally.